Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

P62828 (RAN_RAT) Rattus norvegicus (Rat)

GTP-binding nuclear protein Ran UniProtKBInterProSTRINGInteractive Modelling

216 aa; Sequence (Fasta) ; 90 identical sequences

Available Structures

140 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal Structure of Nucleoporin NUP50 Ran-Binding Domain in Complex with Ran-GPPNHP Heteromer
P62826; Q9UKX7;
6-216
GNP;MG;
Assess
MVM NES mutant Nm2 in complex with CRM1-Ran-RanBP1 Heteromer
P0DJZ2; P30822; P41920; P62826;
7-216
GTP;MG;EDO;GOL;NA;
Assess
MVM NES mutant Nm12 in complex with CRM1-Ran-RanBP1 Heteromer
P0DJZ2; P30822; P41920; P62826;
7-216
GTP;MG;EDO;GOL;CL;NA;
Assess
Crystal Structure of Nup358/RanBP2 Ran-binding domain 1 in complex with Ran-GPPNHP Heteromer
P49792; P62826;
7-216
GNP;MG;
Assess
MVM NS2 mutant Nm42 in complex with CRM1-Ran-RanBP1 Heteromer
P0DJZ2; P30822; P41920; P62826;
7-216
GTP;MG;EDO;GOL;NA;
Assess
MVM NES mutant Nm13 in complex with CRM1-Ran-RanBP1 Heteromer
P0DJZ2; P30822; P41920; P62826;
7-216
GTP;MG;EDO;GOL;NA;
Assess
MVM NS2 NES in complex with CRM1-Ran-RanBP1 Heteromer
P0DJZ2; P30822; P41920; P62826;
7-216
GTP;MG;EDO;GOL;NA;
Assess
Crystal Structure of Nup358/RanBP2 Ran-binding domain 3 in complex with Ran-GPPNHP Heteromer
P49792; P62826;
7-216
GNP;MG;
Assess
MVM NES mutant Nm15 in complex with CRM1-Ran-RanBP1 Heteromer
P0DJZ2; P30822; P41920; P62826;
7-216
GTP;MG;
Assess
Crystal structure of CRM1 inhibitor Leptomycin B in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
8-216
GNP;MG;EDO;LMB;GOL;CL;
Assess
Crystal structure of KPT276 in complex with CRM1-Ran-RanBP1 Heteromer
P41920; P62826;
8-216
GNP;MG;EDO;GOL;K76;CL;
Assess
Crystal Structure of KPT-330 bound to CRM1 (537-DLTVK-541 to GLCEQ) Heteromer
P30822; P41920; P62826;
8-216
GNP;MG;GOL;V6A;
Assess
Crystal structure of CRM1 inhibitor Leptomycin B in complex with CRM1(537DLTVK541/GLCEQ)-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
8-216
GNP;MG;EDO;LMB;GOL;CL;
Assess
Crystal Structure of mDia2 NES Peptide in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826; Q9NSV4;
8-216
GNP;MG;GOL;
Assess
Yeast CRM1e (apo) in complex with Ran-RanBP1 Heteromer
P30822; P41920; P62826;
8-216
MG;GOL;GTP; 12×CL;DMS;MPO;
Assess
Crystal Structure of CPEB4 NES Peptide in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826; Q17RY0;
8-216
GNP;MG;GOL;CL;
Assess
Crystal structure of KPT185 in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
8-216
GNP;MG;EDO;K85;GOL;CL;
Assess
B27 in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
8-216
MG;GOL;GTP;DMS;CL;M9R;
Assess
Zafirlukast in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
8-216
MG;DMS;EDO;GTP;CL;NA;GOL;MPO;ZLK;
Assess
F1 in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
8-216
MG;GOL;GTP;CL;DMS;N59;
Assess
G6 in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
8-216
MG;GOL;GTP; 11×CL;DMS;MPO;MBI;
Assess
Crystal structure of CRM1 inhibitor Ratjadone A in complex with CRM1(K579A)-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
8-216
RJA;GOL;EDO;CL;GNP;MG;
Assess
B28 in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
8-216
MG;GOL;GTP;BR;CL;NA;N5X;
Assess
RanY197A in complex with RanBP1-CRM1 Heteromer
P30822; P41920; P62826;
8-216
GTP;MG;EDO;CL;GOL;ACT;
Assess
RanL182A in complex with RanBP1-CRM1 Heteromer
P30822; P41920; P62826;
8-216
GTP;MG;EDO;GOL;CL;
Assess
LFS829 in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
8-216
GTP;MG;D29;CL;
Assess
Oridonin in complex with CRM1#-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
8-216
MG;EDO;GTP;CL;ODN;
Assess
Crystal Structure of the ZnF1 of Nucleoporin NUP153 in complex with Ran-GDP Heteromer
P49791; P62826;
1-208
GDP;MG;ZN;
Assess
Crystal structure of CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
9-216
GNP;MG;GOL;EDO;CL;
Assess
NCI-1 in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
9-216
MG;GTP;DMS;CL;G6U;GOL;MPO;
Assess
Crystal structure of CRM1 inhibitor Leptomycin B in complex with CRM1(R543S,K548E,K579Q)-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
9-216
GNP;MG;CL;LBF;
Assess
Crystal structure of CRM1 inhibitor Leptomycin B in complex with CRM1(K548A)-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
9-216
GNP;MG;GOL;EDO;LMB;CL;
Assess
Crystal Structure of KPT-185 bound to CRM1 (E582K, 537-DLTVK-541 to GLCEQ) Heteromer
P30822; P41920; P62826;
9-216
GNP;MG;K85;
Assess
Crystal Structure of KPT-330 bound to CRM1 (E582K, 537-DLTVK-541 to GLCEQ) Heteromer
P30822; P41920; P62826;
9-216
GNP;MG;GOL;V6A;
Assess
Crystal structure of CRM1 inhibitor Ratjadone A in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
9-216
GNP;MG;EDO;RJA;GOL;CL;
Assess
Crystal structure of CRM1 inhibitor Anguinomycin A in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
9-216
GNP;MG;CL;AA8;
Assess
Crystal Structure of MVM NS2 NES Peptide in complex with CRM1-Ran-RanBP1 Heteromer
P0DJZ2; P30822; P41920; P62826;
9-216
GNP;MG;GOL;CL;
Assess
KL2 in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
9-216
MG; 14×NO3;GOL;GTP;GLU;CL;DMS;MFF;
Assess
RanM189D in complex with RanBP1-CRM1 Heteromer
P30822; P41920; P62826;
9-216
GTP;MG;EDO;CL;GOL;
Assess
KL1 in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
9-216
MG; 17×NO3;GOL;GTP;CL;DMS;MI8;
Assess
Crystal Structure of HDAC5 NES Peptide in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826; Q9UQL6;
9-216
GNP;MG;GOL;
Assess
Crystal Structure of DEAF1 Peptide in complex with CRM1 K579A mutant-Ran-RanBP1 Heteromer
O75398; P30822; P41920; P62826;
9-216
GNP;MG;GOL;
Assess
Plumbagin in complex with CRM1#-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
9-216
MG;GOL;NO3;GTP;CL;DMS;F2X;
Assess
Crystal Structure of KPT-8602 bound to CRM1 (E582K, 537-DLTVK-541 to GLCEQ) Heteromer
P30822; P41920; P62826;
9-216
GNP;MG;6L8;
Assess
Crystal Structure of PKINES peptide bound to CRM1 Heteromer
P30822; P41920; P61925; P62826;
9-216
GNP;MG;GOL;
Assess
Crystal structure of CRM1 inhibitor Leptomycin B in complex with CRM1(K541Q,K542Q,R543S,K545Q,K548Q… Heteromer
P30822; P41920; P62826;
9-216
GNP;MG;LBF;CL;
Assess
Crystal structure of KPT251 in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
9-216
GNP;MG;EDO;CL;51K;GOL;
Assess
Crystal Structure of FMRP NES Peptide in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826; Q06787;
9-216
GNP;MG;GOL;
Assess
Crystal Structure of SMAD4 NES Peptide in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826; Q13485;
9-216
GNP;MG;GOL;CL;
Assess
Crystal Structure of CDC7 NES Peptide (extended) in complex with CRM1-Ran-RanBP1 Heteromer
O00311; P30822; P41920; P62826;
9-216
GNP;MG;GOL;CL;
Assess
Crystal Structure of Paxillin NES Peptide in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P49023; P62826;
9-216
GNP;MG;GOL;
Assess
Crystal Structure of CDC7 NES Peptide in complex with CRM1-Ran-RanBP1 Heteromer
O00311; P30822; P41920; P62826;
9-216
GNP;MG;GOL;
Assess
Crystal Structure of hRio2 NES Reverse Mutant Peptide in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
9-216
GNP;MG;GOL;ZN;CL;
Assess
Crystal Structure of hRio2 NES Peptide in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826; Q9BVS4;
9-216
GNP;MG;GOL;CL;ZN;
Assess
Crystal Structure of the 4E-TNES peptide bound to CRM1 Heteromer
P30822; P41920; P62826; Q9NRA8;
9-216
GNP;MG;GOL;
Assess
Plumbagin in complex with CRM1-RanM189D-RanBP1 Heteromer
P30822; P41920; P62826;
9-216
GTP;MG;CL;NO3;F2X;NA;
Assess
Crystal structure of CRM1 inhibitor Leptomycin B in complex with CRM1(K548E,K579Q)-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
9-216
GNP;MG;EDO;LMB;CL;
Assess
KL2.1 in complex with CRM1-Ran-RanBP1 Heteromer
A0A6A5PZB5; A0A6A5PZI8; P62826;
9-216
MG; 14×NO3;DMS;GOL;GTP;CL;ACT;Q73;
Assess
Crystal Structure of mDia2NES peptide bound to CRM1(E571K) Heteromer
P30822; P41920; P62826; Q9NSV4;
9-216
GNP;MG;GOL;EDO;
Assess
Crystal Structure of Hxk2 Peptide in complex with CRM1 K579A mutant-Ran-RanBP1 Heteromer
P04807; P30822; P41920; P62826;
9-216
GNP;MG;GOL;
Assess
Crystal Structure of Engineered FMRP-1b NES Peptide in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826; Q06787;
9-216
GNP;MG;GOL;
Assess
Crystal Structure of unliganded CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
9-216
GNP;MG;GOL;
Assess
Crystal Structure of X11L2 NES Peptide in complex with CRM1-Ran-RanBP1 Heteromer
O96018; P30822; P41920; P62826;
9-216
GNP;MG;GOL;
Assess
Crystal Structure of the Mek1NES peptide bound to CRM1 Heteromer
P30822; P41920; P62826; Q02750;
9-216
GNP;MG;GOL;
Assess
Crystal Structure of KPT-8602 bound to CRM1 (537-DLTVK-541 to GLCEQ) Heteromer
P30822; P41920; P62826;
9-216
GNP;MG;6L8;
Assess
Crystal Structure of Mek1NES peptide bound to CRM1(E571K) Heteromer
P30822; P41920; P62826; Q02750;
9-216
GNP;MG;GOL;
Assess
Crystal Structure of Mek1(NQ)NES peptide bound to CRM Heteromer
P30822; P41920; P62826; Q02750;
9-216
GNP;MG;GOL;
Assess
Crystal Structure of KPT8602 in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
9-216
GNP;MG;GOL;CL;6L8;
Assess
S109 in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
9-216
GTP;MG;NO3;CL;EQF;GOL;
Assess
Crystal Structure of PKI NES Flip Mutant Peptide in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P61925; P62826;
9-216
GNP;MG;GOL;
Assess
Crystal Structure of unliganded CRM1(E571K)-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
9-216
GNP;MG;
Assess
Crystal structure of CRM1(T539S)-Ran-RanBP1 with weakly bound unmodeled Leptomycin B Heteromer
P30822; P41920; P62826;
9-216
GNP;MG;CL;
Assess
Crystal Structure of KPT-185 bound to CRM1 (537-DLTVK-541 to GLCEQ) Heteromer
P30822; P41920; P62826;
9-216
GNP;MG;K85;
Assess
Crystal Structure of PKI(DE)NES peptide bound to CRM1 Heteromer
P30822; P41920; P61925; P62826;
9-216
GNP;MG;GOL;
Assess
Crystal Structure of CPEB4 NES Reverse Mutant Peptide in complex with CRM1-Ran-RanBP1 Heteromer
P30822; P41920; P62826;
9-216
GNP;MG;GOL;
Assess
Crystal Structure of PKINES peptide bound to CRM1(E571K) Heteromer
P30822; P41920; P61925; P62826;
9-216
GNP;MG;GOL;
Assess
Crystal Structure of Nup358/RanBP2 Ran-binding domain 2 in complex with Ran-GPPNHP Heteromer
P49792; P62826;
7-213
GNP;MG;
Assess
Ran Y39A in complex with GPPNHP and RanBD1 Heteromer
P49792; P62826;
5-211
GNP;MG;SO4;
Assess
Crystal Structure of Nup358/RanBP2 Ran-binding domain 4 in complex with Ran-GPPNHP Heteromer
P49792; P62826;
6-211
GNP;MG;
Assess
Structure of the NTF2:RanGDP complex Heteromer
P61972; P62825;
7-212
GDP;MG;SO4;
Assess
Crystal structure of Ran-GPPNHP-RanBP1-RanGAP complex Heteromer
P41391; P43487; P62826;
8-213
MG;GNP;
Assess
Crystal structure of Ran-GDP-AlFx-RanBP1-RanGAP complex Heteromer
P41391; P43487; P62826;
8-213
MG;GDP;AF3;
Assess
Crystal structure of human RanGDP-Nup153ZnF34 complex Heteromer
P49791; P62826;
6-209
MG;GDP;ZN;
Assess
Crystal Structure of the ZnF3 of Nucleoporin NUP153 in complex with Ran-GDP, resolution 2.05 Angstr… Heteromer
P49791; P62826;
7-210
GDP;MG;ZN;
Assess
Crystal Structure of the ZnF3 of Nucleoporin NUP153 in complex with Ran-GDP, resolution 2.4 Angstrom Heteromer
P49791; P62826;
7-210
GDP;MG;ZN;
Assess
STRUCTURE OF THE RAN-GPPNHP-RANBD1 COMPLEX Heteromer
P49792; P62826;
8-211
MG;GNP;
Assess
Crystal Structure of the ZnF8 of Nucleoporin NUP358/RanBP2 in complex with Ran-GDP Heteromer
P49792; P62826;
7-209
GDP;GOL;MG;ZN;
Assess
Crystal Structure of the ZnF3 of Nucleoporin NUP358/RanBP2 in complex with Ran-GDP Heteromer
P49792; P62826;
6-208
GDP;MG;ZN;
Assess
Crystal structure of human RanGDP-Nup153ZnF1 complex Heteromer
P49791; P62826;
6-208
MG;GDP;ZN;
Assess
Crystal Structure of the ZnF4 of Nucleoporin NUP153 in complex with Ran-GDP Heteromer
P49791; P62826;
7-208
GDP;MG;ZN;
Assess
Crystal structure of human RanGDP-Nup153ZnF2 complex Heteromer
P49791; P62826;
6-207
MG;GDP;ZN;
Assess
Crystal Structure of the ZnF2 of Nucleoporin NUP358/RanBP2 in complex with Ran-GDP Heteromer
P49792; P62826;
7-208
GDP;MG;ZN;
Assess
Crystal Structure of the ZnF4 of Nucleoporin NUP358/RanBP2 in complex with Ran-GDP Heteromer
P49792; P62826;
7-208
GDP;MG;ZN;
Assess
Crystal Structure of the ZnF2 of Nucleoporin NUP153 in complex with Ran-GDP Heteromer
P49791; P62826;
8-208
GDP;MG;ZN;
Assess
Crystal structure of human RanGDP-Nup153ZnF4 complex Heteromer
P49791; P62826;
8-208
MG;GDP;ZN;
Assess
Crystal structure of human RanGDP-Nup153ZnF12 complex Heteromer
P49791; P62826;
7-207
MG;GDP;ZN;
Assess
Crystal Structure of the ZnF2 of Nucleoporin NUP358/RanBP2 in complex with Ran-GDP Heteromer
P49792; P62826;
7-207
GDP;MG;ZN;
Assess
Crystal structure of human RanGDP-Nup153ZnF3 complex Heteromer
P49791; P62826;
8-208
MG;GDP;ZN;
Assess
Crystal Structure of the ZnF5 or ZnF6 of Nucleoporin NUP358/RanBP2 in complex with Ran-GDP Heteromer
P49792; P62826;
8-208
GDP;MG;ZN;
Assess
Crystal Structure of the ZnF7 of Nucleoporin NUP358/RanBP2 in complex with Ran-GDP Heteromer
P49792; P62826;
7-206
GDP;MG;ZN;
Assess
The crystal structure of the RanGDP-Nup153ZnF2 complex Heteromer
P49791; P62826;
7-205
MG;SO4;GDP;ZN;
Assess
STRUCTURE OF THE KARYOPHERIN BETA2-RAN GPPNHP NUCLEAR TRANSPORT COMPLEX Heteromer
P62826; Q92973;
8-197
MG;GNP;
Assess
Truncated Ran wild type in complex with GDP-BeF and RanBD1 Heteromer
P49792; P62826;
8-186
GDP;BEF;MG;
Assess
Human CRM1-RanGTP in complex with Leptomycin B Heteromer
O14980; P62826;
6-180
GTP;MG;LMB;
Assess
Kap95p Binding Induces the Switch Loops of RanGDP to adopt the GTP-bound Conformation: Implications… Heteromer
P62826; Q06142;
6-179
GDP;MG;
Assess
Crystal structure of human CRM1 covalently modified by 2-mercaptoethanol at Cys528 Heteromer
O14980; P62826;
6-179
GTP;MG;BME;
Assess
Crystal structure of the HIV-1 Rev NES-CRM1-RanGTP nuclear export complex (crystal I) Heteromer
O95149; P62826; Q6P5F9;
8-180
GTP;MG;NA;
Assess
Crystal structure of the HIV-1 Rev NES-CRM1-RanGTP nuclear export complex (crystal II) Heteromer
O95149; P62826; Q6P5F9;
8-180
GOL; 11×PEG;IPH;GTP;MG;
Assess
Crystal structure of RanGTP-Exportin 4-eIF5A complex Heteromer
P62826; P63241; Q9ESJ0;
7-179
GTP;MG;
Assess
Crystal structure of the CRM1-RanGTP complex Heteromer
P62826; Q6P5F9;
8-180
GTP;MG;
Assess
Crystal structure of a CRM1-RanGTP-SPN1 export complex bound to a 113 amino acid FG-repeat containi… Heteromer
O14980; O95149; P0AEX9; P35658; P62826;
8-179
GLC;PRO;GTP;MG;
Assess
Crystal structure of transportin-SR2, a karyopherin involved in human disease, in complex with Ran Heteromer
P62826; Q9Y5L0;
8-179
MG;GTP;
Assess
Crystal Structure of the Nuclear Export Complex CRM1-Snurportin1-RanGTP Heteromer
O95149; P62826; Q6P5F9;
9-179
NA;GTP;MG;
Assess
Crystal structure of Kap121p bound to RanGTP Heteromer
P32337; P62825;
6-176
MG;GTP;
Assess
Crystal structure of the biportin Pdr6 in complex with RanGTP Heteromer
P32767; P62826;
8-178
GTP;MG;
Assess
Crystal structure of the PKI NES-CRM1-RanGTP nuclear export complex Heteromer
O95149; P62826; Q6P5F9;
9-179
GTP;MG;
Assess
Crystal structure of RanGTP-Pdr6-eIF5A export complex Heteromer
P23301; P32767; P62826;
8-178
GTP;MG;
Assess
Cryo-EM structure of Ran bound to RCC1 and the nucleosome core particle Heteromer
P02283; P02299; P18754; P62826; P84040; P84051;
7-177
Assess
RAN-RCC1-SO4 COMPLEX Heteromer
P18754; P62826;
8-177
SO4;
Assess
Structure of the Cse1:Imp-alpha:RanGTP complex Heteromer
P33307; P62825; Q02821;
7-176
GTP;MG;
Assess
Crystal structure of Exportin-5:RanGTP:pre-miRNA complex Heteromer
P62825; Q9HAV4;
7-176
GTP;MG;
Assess
CRYSTAL STRUCTURE OF EXPORTIN-5:RANGTP COMPLEX Heteromer
P62825; Q9HAV4;
7-176
GTP;MG;
Assess
COMPLEX OF RAN WITH IMPORTIN BETA Heteromer
P62826; Q14974;
9-177
MG;GNP;
Assess
Kap95p:RanGTP complex Heteromer
P62825; Q06142;
9-177
GTP;MG;
Assess
Transportin 3 in complex with Ran(Q69L)GTP Heteromer
P62826; Q9Y5L0;
9-177
MG;GTP;
Assess
Crystal Structure of Importin 13 - RanGTP - eIF1A complex Heteromer
O94829; P47813; P62826;
9-177
GTP;MG;
Assess
Sirt2 in complex with a 13-mer trifluoroacetylated Ran peptide Heteromer
P62826; Q8IXJ6;
33-40
SO4;ZN;
Assess
CANINE GDP-RANhomo-2-mer2-216
MG;GDP;
Assess
Structural Characterization of the Mengovirus Leader Protein Bound to Ran GTPase by Nuclear Magneti…monomer1-216
Assess
NMR solution structure of nucleotide-free Ran GTPasemonomer1-216
Assess
Nucleotide-free human ran gtpasemonomer1-216
Assess
Crystal structure of human RanGDPmonomer2-207
MG;GDP;
Assess
CANINE GDP-RAN F72Y MUTANTmonomer6-207
MG;GDP;
Assess
CANINE GDP-RAN Q69L MUTANTmonomer5-205
MG;GDP;
Assess
CANINE GDP-RAN R76E MUTANTmonomer8-208
MG;GDP;
Assess
Ran GDP wild type tetragonal crystal formmonomer9-207
GDP;MG;
Assess
Ran GDP wild type monoclinic crystal formmonomer8-206
GDP;MG;
Assess
Ran GDP Y39A mutant monoclinic crystal formmonomer9-207
GDP;MG;
Assess
Ran GDP Y39A mutant triclinic crystal formmonomer8-204
GDP;MG;
Assess
crystal structure of human REV7-RAN complexmonomer167-185
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4gpt.1.Amonomer0.839-216
GNP;100.00
Assess
2mmc.1.Amonomer0.811-216
100.00
Assess